SCN2A and autism: Cells in the later pseudotime stage exhibited specific enrichment in synaptic pathways, characterized by the upregulation of several neuronal markers, including CUX2, glutamate metabotropic receptor genes (GRM1, GRM2, and GRM3), and several autism risk genes, including PTEN, SCN2A, and SHANK2.